Government
Rhode Island, Mississippi, Maryland lead 2022 marijuana legalization via legislatures
(This story has been updated to correct the number of dispensary licenses that can be owned by one entity in Mississippi.)
Marijuana legalization advocates have had mixed success so far this year in statehouses across the country.
They’ve scored legislative victories in Rhode Island, Mississippi and Maryland, laying the groundwork for hundreds of millions of dollars in combined sales for recreational and medical cannabis companies in those states.
At the same time, however, industry advocates have suffered defeats in several states, including Kansas, North Carolina and South Carolina.
Those losses underscore the hurdles cannabis industry advocates face in states where Republicans control one or both houses of the legislature and/or the governor’s mansion.
Now that more state legislatures have adjourned for the year, here’s a summary of the industry victories as the first half of 2022 winds to a close:
- Rhode Island became the 19th state to legalize recreational marijuana. The market is expected to launch Dec. 1, with existing medical cannabis operators getting the first crack at sales.
- Mississippi became the 39th state to legalize medical marijuana, a year after the state’s highest court voided a voter-approved referendum. The state opened its licensing-application process earlier this month and is on track for sales to start by the end of the year or early 2023.
- Maryland lawmakers referred the issue of recreational marijuana to voters, who are expected to approve a legalization initiative in November. Assuming the measure passes, lawmakers will need to agree on a licensing and regulatory structure. Sales are expected to start in 2024 or 2025.
Elsewhere, Pennsylvania’s Legislature remains in session, and the state faces increasing pressure to legalize adult-use sales to match neighboring New Jersey.
But Senate Republicans in Pennsylvania remain a formidable obstacle, and legalization this year would be a big surprise.
While legalization bills failed in a number of other states, they did advance further along than previously in Delaware (recreational), North Carolina (medical) and South Carolina (medical).
A slim chance remains that North Carolina lawmakers could approve a medical marijuana measure. But experts don’t expect it to pass this year.
“Almost all of the states that have not yet legalized have GOP control over one or both chambers and/or the governor’s mansion,” Karen O’Keefe, state policies director for the Washington DC-based Marijuana Policy Project (MPP), told MJBizDaily.
“Delaware and Hawaii are the only two states with a Democratic trifecta that haven’t legalized (recreational marijuana) yet, and both states’ governors are opposed,” O’Keefe added in an email.
In short, O’Keefe wrote, “the low-hanging fruit has been picked, and more challenging states remain. And even in states with Democratic trifectas, it took years of organizing and work to get legalization past the finish line.”
O’Keefe added that while states continue to legalize marijuana in some form, lawmakers in most states continue to lag far behind their constituents when it comes to supporting legalization.
She also noted that, for the first time, a Democratic governor actually spiked a legalization bill.
Delaware Gov. John Carney vetoed a bill that would have legalized marijuana possession and gifting. The measure would not have established a commercial marijuana market.
In addition to legislative activity, as many as five marijuana legalization measures could be on state ballots this fall.
South Dakota already has qualified an adult-use measure, and Arkansas, Missouri, North Dakota and Oklahoma remain possibilities, O’Keefe wrote.
South Dakota’s is a narrow referendum that would legalize possession and home cultivation. But it would not pave the way for a commercial marijuana market.
Here’s a more detailed look at the three states where legalization legislative victories have been secured this year:
Rhode Island
Existing medical cannabis dispensaries, called compassion centers in Rhode Island, will be able to obtain a hybrid license on Dec. 1 to begin adult-use sales.
Medical marijuana operators will need to pay $125,000 into a social equity fund, according to a bill summary from MPP.
The existing industry is small. The state issued five additional medical marijuana dispensary licenses last October, but that will increase the number of retail outlets across the state only to nine.
Here are some other key business details involving the legalization bill:
- New retail licensing: In addition to the existing MMJ operators, 24 new retail recreational marijuana licenses will be issued across six geographic regions. That will include at least one social equity permit and one worker-owned cooperative license in each geographic region. Retailers will be required to establish a so-called labor peace agreement with a union.
- Cultivation: While Rhode Island doesn’t have many retail outlets, the state has more than 60 MMJ cultivators. They will be granted adult-use licenses provided they are in good standing. The state will have a moratorium on issuing new cultivation licenses for two years after adult-use rules and regulations are finalized.
- Local bans: Municipalities can opt out of the adult-use industry, except in areas that currently have medical cannabis dispensaries.
- Taxes: A retail excise tax of 10% will be implemented in addition to the current sales tax of 7%. A local tax of 3% also may be implemented.
Mississippi
Medical cannabis regulators in Mississippi opened the licensing application process in June for growers, processors, testing facilities and transporters, but it could be year-end or early 2023 before sales start.
There is no cap on the number of licenses the state can issue, but the law allows municipalities to opt out.
Eighty municipalities and 19 counties had decided to ban dispensaries as of May 23, according to state Department of Revenue data. Residents in those municipalities could petition for a referendum on the issue.
The most restrictive provisions involve purchase limits and product-potency caps.
Patient purchases will be limited to about 3 ounces of marijuana a month. That’s lower than the 5-ounce-a-month limit in the 2020 referendum that was passed but later thrown out by the courts.
Lawmakers also imposed a potency cap of 30% THC for flower and 60% for concentrates, oils and tinctures.
Other key business elements include:
- Cultivation: MMJ must be grown indoors. There will be six cultivation tiers, ranging from a micro-cultivator capped at 1,000 square feet to a Tier 6 grower with 100,000 square feet or more.
- Seed-to-sale: A tracking system will be created, and the new law calls for criminal penalties for violations.
- Ownership: No individual or business will be allowed to have more than a 10% ownership interest in more than one cultivation license, one processing license or five dispensary licenses.
- Taxes: A 5% excise tax will be imposed on wholesale in addition to the state sales tax (currently 7%) for retail sales.
The 2022 MJBizFactbook projects that Mississippi medical marijuana sales will reach $80 million to $97.5 million in the first full year and as much as $627 million by 2026.
Maryland
Lawmakers in Maryland referred recreational marijuana legalization to the voters in November. The resulting ballot measure is expected to pass.
It won’t be such a quick process to market launch, however.
Assuming voters approve legalization, lawmakers will need to agree on a licensing and regulatory structure.
That process could be completed in the 2023 legislative session, but some final details might extend into 2024.
That’s because lawmakers are hesitant to act before the expected release in mid-2023 of a so-called “disparity study” that will help determine how to develop a diverse, equitable recreational marijuana industry.
Once a regulatory structure is in place, it will take another year or so for final regulations to be developed, licensing to take place and businesses to build their operations.
Some industry officials say that could push a market launch to 2025.
Business
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.
The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.
Golden Roots operates the The Cannabis Revolution Dispensary.
The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.
The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.
Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.
After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.
In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.
The company requested a hearing, which the regulator scheduled for Sept. 1.
At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.
Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.
Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.
The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:
- Regulators alleged in August that Albuquerque dispensary Sawmill Sweet Leaf sold out-of-state products and didn’t have a license for extraction.
- Paradise Exotics Distro lost its license in July after regulators alleged the company sold products made in California.
Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.
Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/
Business
Marijuana companies suing US attorney general in federal prohibition challenge
Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.
According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”
Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.
The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”
The companies want the case to go before the U.S. Supreme Court.
They hired prominent law firm Boies Schiller Flexner to represent them.
The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.
Similar challenges to the federal Controlled Substances Act (CSA) have failed.
One such challenge led to a landmark Supreme Court decision in 2005.
In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.
In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.
Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.
“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.
“Moreover, the facts on which those precedents are based are no longer true.”
Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”
While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.
“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”
Business
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.
The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).
Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.
Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.
That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.
Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.
Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.
A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.
Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/
-
Business1 year ago
Pot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business1 year ago
New Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business1 year ago
Alabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business1 year ago
Washington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business1 year ago
Marijuana companies suing US attorney general in federal prohibition challenge
-
Business1 year ago
Legal Marijuana Handed A Nothing Burger From NY State
-
Business1 year ago
Can Cannabis Help Seasonal Depression
-
Blogs1 year ago
Cannabis Art Is Flourishing On Etsy